Pharma needs to focus on drug formulation earlier in development cycle

With sponsorship and support from Rentschler and Leukocare, Informa Pharma Intelligence conducted a survey of senior executives to identify company commitments to drug formulation and understand what and where the bottlenecks are in the development process. Rentschler SVP Business Development Federico Pollano and Leukocare CEO Michael Scholl talked to Mike Ward during BIO-Europe 2018, discussing the key conclusions of the survey and highlighting how more emphasis on formulation by commercial functions within companies could have a dramatic impact on drug development success.